M. J. PARRY

ADMINISTRATION TO MAN OF UK-37,248-01, A SELECTIVE INHIBITOR OF THROMBOXANE SYNTHETASE

H. M. Tyler, CraigA.P.D. Saxton, M. J. PARRY · The Lancet · 1981 · 166 citations

Life Sciences, Pharmacology, Enzymology +2

UK-37,248, A novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity

Michael J. Randall, M. J. PARRY, Edward Hawkeswood et al. · Thrombosis Research · 1981 · 116 citations

Medicine, Pharmacology, Pharmacotherapy +14

1,4-Dihydropyridines as antagonists of platelet activating factor. 1. Synthesis and structure-activity relationships of 2-(4-heterocyclyl)phenyl derivatives

Kelvin Cooper, M. Jonathan Fray, M. J. PARRY et al. · Journal of Medicinal Chemistry · 1992 · 101 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Piroxicam, a structurally novel anti-inflammatory compound. Mode of prostaglandin synthesis inhibition

Thomas J. Carty, Joann S Stevens, Joseph G. Lombardino et al. · Prostaglandins · 1980 · 67 citations

Medicine, Medicinal Chemistry, Pharmacology +12

Digital Curation in the Digital Humanities: Preserving and Promoting Archival and Special Collections

M. J. PARRY · The Electronic Library · 2016 · 46 citations

Humanities, Heritage Conservation, Digital Humanities +15